Applied Therapeutics Inc. (APLT)
NASDAQ: APLT
· Real-Time Price · USD
0.48
-0.03 (-5.70%)
At close: Jul 25, 2025, 3:59 PM
0.50
4.79%
After-hours: Aug 21, 2025, 07:46 PM EDT
Applied Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 122K | 266K | 456K | -211K | -333K | -477K | 9.99M | 10.66M | 10.66M | 10.66M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 288K | 410K | 425K | 15.65M | 15.66M | 15.65M | 15.54M | 346K | 339K | 333K | 441K | 435K | 428K | 423K | 415K | 308K | 204K | 100K |
Gross Profit | -62K | -40K | 135K | -15.76M | -15.99M | -16.13M | -5.54M | 10.31M | 10.32M | 10.33M | -441K | -435K | -428K | -423K | -415K | -308K | -204K | -100K |
Operating Income | -111.39M | -108.73M | -104.3M | -92.28M | -78.04M | -74.77M | -64.54M | -62.5M | -66.36M | -70.71M | -82.95M | -91.09M | -100.17M | -104.52M | -105.62M | -102.25M | -103.79M | -106.19M |
Interest Income | 3.3M | 3.57M | 3.53M | 2.92M | 1.96M | 1.74M | 1.37M | 1.48M | 1.31M | 1.02M | 872K | 414K | 263K | 321K | 245K | 369K | 424K | 255K |
Pretax Income | -67.74M | -43.51M | -105.62M | -187.31M | -161.09M | -193.56M | -119.76M | -96.51M | -73.24M | -69.52M | -82.51M | -95.24M | -104.56M | -104.53M | -105.58M | -102.11M | -103.54M | -105.77M |
Net Income | -67.74M | -43.51M | -105.62M | -187.31M | -161.09M | -193.56M | -119.76M | -87.9M | -64.34M | -69.09M | -82.02M | -103.36M | -112.97M | -104.47M | -105.58M | -102.11M | -103.54M | -105.77M |
Selling & General & Admin | 67.15M | 64.55M | 55.93M | 39.72M | 29.39M | 24.11M | 20.62M | 22.47M | 24M | 24.83M | 27.32M | 31.83M | 36.42M | 41.37M | 43.05M | 41.59M | 40.78M | 37.23M |
Research & Development | 44.28M | 44.36M | 48.74M | 52.35M | 48.31M | 50.19M | 53.91M | 50.7M | 53.03M | 56.54M | 55.63M | 59.27M | 63.75M | 63.15M | 62.57M | 60.66M | 63.01M | 68.97M |
Other Expenses | 80K | -42K | -161K | -15.54M | -15.66M | -15.54M | -15.43M | -106K | 4K | -81K | -177K | -194K | -250K | -282K | -242K | -241K | -187K | -27K |
Operating Expenses | 111.51M | 108.87M | 104.51M | 76.53M | 62.04M | 58.76M | 59.11M | 73.04M | 77.02M | 81.37M | 82.95M | 91.09M | 100.17M | 104.52M | 105.62M | 102.25M | 103.79M | 106.19M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 555K | 555K | 555K | 631K | 635K | 635K | 818K |
Selling & Marketing Expenses | n/a | 127K | 127K | 127K | 127K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 111.51M | 109M | 104.75M | 92.07M | 77.7M | 74.3M | 74.53M | 73.16M | 77.02M | 81.37M | 82.95M | 91.09M | 100.17M | 104.52M | 105.62M | 102.25M | 103.79M | 106.19M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8.61M | -8.9M | -429K | -485K | 8.13M | 8.34M | -301K | -321K | -322K | -377K | -390K |
Shares Outstanding (Basic) | 145.09M | 144.79M | 139.53M | 14.44M | 49.34M | 125.32M | 84.24M | 90.67M | 79.04M | 56.32M | 49.95M | 48M | 26.9M | 26.22M | 25.98M | 26.18M | 26.08M | 24.14M |
Shares Outstanding (Diluted) | 145.09M | 144.79M | 139.53M | 14.44M | 49.34M | 125.32M | 84.24M | 90.67M | 79.04M | 56.36M | 49.95M | 48M | 26.9M | 26.22M | 26.18M | 26.18M | 26.08M | 24.14M |
EPS (Basic) | -4.73 | -4.56 | -5.08 | -5.85 | -1.57 | -1.96 | -1.47 | -1.14 | -1.07 | -1.98 | -2.68 | -3.61 | -4.3 | -4.01 | -4.13 | -4.06 | -4.3 | -4.58 |
EPS (Diluted) | -4.73 | -4.71 | -5.23 | -6 | -1.72 | -1.96 | -1.47 | -1.14 | -1.07 | -1.98 | -2.68 | -3.6 | -4.29 | -4 | -4.12 | -4.06 | -4.3 | -4.58 |
EBITDA | -111.1M | -108.32M | -103.87M | -91.93M | -77.67M | -74.41M | -64.18M | -62.04M | -65.91M | -70.26M | -82.51M | -90.66M | -99.74M | -104.1M | -105.2M | -101.84M | -103.39M | -105.8M |
EBIT | -109.62M | -108.73M | -104.3M | -92.28M | -78.04M | -74.77M | -64.54M | -62.5M | -66.36M | -70.71M | -82.95M | -91.09M | -100.17M | -104.52M | -105.62M | -102.25M | -103.79M | -106.19M |
Depreciation & Amortization | 288K | 410K | 425K | 351K | 365K | 358K | 353K | 460K | 453K | 447K | 441K | 435K | 428K | 423K | 415K | 407K | 398K | 387K |